Nanomedicine in the Treatment of Metabolic Diseases

Nanotechnology employed in drug development has led to the origination of enhanced drug delivery systems targeted for the mitigation of metabolic diseases. Metabolic diseases customarily occur due to an imbalance in homeostatic mechanisms in the body. Nanomedicine has enhanced the bioavailability and augmented targeted delivery of drugs to their site of action, thereby reducing the disease burden on humankind. The surge of development of nanodrugs in the last decade has led to the emergence of formulations approved by the Food and Drug Administration (FDA). Treatments of diabetes, obesity, nonalcoholic fatty liver disease, and endothelial dysfunctions have been explored with nanotechnology to combat the sufferings.